We are live on ! Find out more
TC

Truvestments Capital Portfolio holdings

AUM $554M
1-Year Est. Return 32.49%
This Fund
S&P 500
This Quarter Est. Return
+5.99%
1 Year Est. Return
+32.49%
3 Year Est. Return
+86.71%
5 Year Est. Return
+90.42%
10 Year Est. Return
–
AUM
$182M
AUM Growth
+$5.25M
Cap. Flow
-$6.66M
Cap. Flow %
-3.66%
Top 10 Hldgs %
17.92%
Holding
715
New
45
Increased
152
Reduced
213
Closed
90

Top Buys

Rank Stock Value
1
WPC icon
W.P. Carey
WPC
+$382K
2
SBUX icon
Starbucks
SBUX
+$376K
3
STAG icon
STAG Industrial
STAG
+$374K
4
BRMK
Broadmark Realty Capital Inc. Common Stock
BRMK
+$373K
5
PDCO
Patterson Companies, Inc.
PDCO
+$372K

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$2.96M
2
AMZN icon
Amazon
AMZN
+$1.96M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.18M
4
NEE icon
NextEra Energy
NEE
+$1.01M
5
PFE icon
Pfizer
PFE
+$705K

Sector Composition

Rank Sector Weight
1 Technology 23.55%
2 Real Estate 13.23%
3 Industrials 11.56%
4 Healthcare 11.12%
5 Consumer Staples 8.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNH
526
CNH Industrial
CNH
$17.5B
$3K ﹤0.01%
179
– –
CSCI
527
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$3K ﹤0.01%
29
– –
TVRD
528
Tvardi Therapeutics
TVRD
$23.4M
$3K ﹤0.01%
7
– –
CBAY
529
DELISTED
Cymabay Therapeutics
CBAY
$3K ﹤0.01%
727
– –
MRTX
530
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$3K ﹤0.01%
17
– –
PACW
531
DELISTED
PacWest Bancorp
PACW
$3K ﹤0.01%
65
– –
DBD
532
DELISTED
Diebold Nixdorf Incorporated
DBD
$3K ﹤0.01%
242
– –
VIVO
533
DELISTED
Meridian Bioscience Inc
VIVO
$3K ﹤0.01%
140
– –
ABMD
534
DELISTED
Abiomed Inc
ABMD
$3K ﹤0.01%
11
– –
POLY
535
DELISTED
Plantronics, Inc.
POLY
$3K ﹤0.01%
60
– –
CALA
536
DELISTED
Calithera Biosciences, Inc
CALA
$3K ﹤0.01%
65
– –
ADMS
537
DELISTED
Adamas Pharmaceuticals
ADMS
$3K ﹤0.01%
637
– –
RNWK
538
DELISTED
RealNetworks Inc
RNWK
$3K ﹤0.01%
1,400
+700
+100% +$2.04K
ABEO icon
539
Abeona Therapeutics
ABEO
$413M
$2K ﹤0.01%
55
– –
ASB icon
540
Associated Banc-Corp
ASB
$5.91B
$2K ﹤0.01%
100
– –
BNDX icon
541
Vanguard Total International Bond ETF
BNDX
$83.1B
$2K ﹤0.01%
35
-477
-93% -$27.2K
CMA
542
DELISTED
Comerica
CMA
$2K ﹤0.01%
34
– –
CMTL icon
543
Comtech Telecommunications
CMTL
$51.8M
$2K ﹤0.01%
90
– –
CRSP icon
544
CRISPR Therapeutics
CRSP
$5.17B
$2K ﹤0.01%
+14
New +$1.7K
DVY icon
545
iShares Select Dividend ETF
DVY
$23.6B
$2K ﹤0.01%
14
-236
-94% -$28.1K
EWBC icon
546
East-West Bancorp
EWBC
$18B
$2K ﹤0.01%
33
– –
EYPT icon
547
EyePoint Inc
EYPT
$1.2B
$2K ﹤0.01%
258
– –
HTHT icon
548
Huazhu Hotels Group
HTHT
$13B
$2K ﹤0.01%
42
– –
IEZ icon
549
iShares US Oil Equipment & Services ETF
IEZ
$364M
$2K ﹤0.01%
110
-110
-50% -$1.61K
LAKE icon
550
Lakeland Industries
LAKE
$119M
$2K ﹤0.01%
100
– –
20 21
22
23 24

Similar funds

CA
Crossingbridge Advisors Pleasantville, New York $553M AUM 1.32% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
CAM
Cander Asset Management New York $557M AUM
TC
Triata Capital Hong Kong $552M AUM 2.89% 1-Year Est. Return
BT
Brandywine Trust Hockessin, Delaware $552M AUM 5.23% 1-Year Est. Return
QL
Quarry LP New York $558M AUM 23.81% 1-Year Est. Return
IQI
Integrated Quantitative Investments Bellevue, Washington $551M AUM 45.27% 1-Year Est. Return
TCM
Thames Capital Management Roseland, New Jersey $558M AUM 236.21% 1-Year Est. Return

Truvestments Capital's Q2 2021 Portfolio in Review

As of Q2 2021, Truvestments Capital held 715 positions worth $182M, up 3% from $177M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Truvestments Capital withdrew a net $6.66M in Q2 2021, closing 90 positions and reducing 213 holdings. Its most notable exit was Marvell Technology, an estimated $486K position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Real Estate and Industrials.

Against the trend, Truvestments Capital opened a new position in Polaris worth $214K.

  • Truvestments Capital's largest Q2 2021 buy was Polaris: 1,565 shares worth $214K.
  • Truvestments Capital added most to W.P. Carey in Q2 2021, an estimated $382K increase.
  • Truvestments Capital's biggest Q2 2021 reduction was Apple, cutting an estimated $2.96M.
  • Truvestments Capital fully exited Marvell Technology in Q2 2021, selling an estimated $486K.
  • Truvestments Capital's ten largest holdings make up 18% of its $182M portfolio in Q2 2021.
  • Truvestments Capital opened 45 new positions and closed 90 in Q2 2021.
  • Truvestments Capital's portfolio value rose 3% quarter-over-quarter to $182M.

Based on Truvestments Capital's 13F filing for Q2 2021, filed 12 Aug 2021.